Atos and Siemens are performing together with the pharmaceutical business to increase manufacturing with an progressive remedy centered on a electronic duplicate of the pharma generation process. This “Process Digital Twin” for pharma manufacturing – run by IoT, AI and Innovative Analytics – is developed to provide enhanced effectiveness and flexibility in the production of pharmaceutical goods. This potentially disruptive solution opens up new options, these kinds of as a sustainable course of action growth – lessening over-all experimentation time and squander, guaranteeing continual quality and moving to new “quality by design” designs to get the product proper the 1st time.
The character of Atos and Siemens’ pre-built-in Digital Twin resolution makes it possible for it to be deployed to manufacturing procedures of any scale or complexity. By changing the technological creating blocks Atos and Siemens can replicate Digital Twin use circumstance to every single new consumer – in just pharmaceutical, chemical, process producing industries and other marketplaces – much more effectively.
Speakers:
Niels Thomsen, VP and Global Head of the Perception (IoT and AI) follow, Atos
Patrick Bossuyt, Digitalization & QbD Manager, Siemens
